EuropaColon is looking for 1,000 patients across Europe to talk part in their new survey “The Unmet Needs of Patients Living with Metastatic Colorectal Cancer”.
By undertaking this survey, EuropaColon is aiming to make a difference to the lives of colorectal cancer patients. By collecting anonymous responses from patients across Europe, the information will be used as a basis for recommendations for change.
Colorectal cancer (CRC) is the most common type of GI cancer in Europe with 68 CRC cases per 100,000 population. The disease has a much higher rate in men: 79 CRC case per 100,000 than women: 54 CRC cases per 100,000. CRC accounted for 342,137 diagnoses and 14.3% of all cancer diagnoses in Europe in 2012.
Healthcare in Europe is different in every country. For example, patients may live in a country where your whole healthcare team supports them from diagnosis and they might have access to the latest treatments and medicines. No matter what a patient’s experience has been, EuropaColon is interested to hear what patients have to say.
EuropaColon is the voice of colorectal cancer patients in Europe and aims to save lives by bringing together all key stakeholders in the fight against this deadly disease, which is highly treatable if diagnosed early.
EuropaColon is working with Affiliates and Associates to prioritise and raise the profile of digestive cancers in Europe. The aim is to promote and encourage increased awareness of the symptoms and prevention of these cancers.